t: +44 (0) 1727 809917

e: info@healthcare-ed.com

web stats

Introduction to Cancer: Focus on Solid Tumors

25-26 Apr 2018 Newark, NJ, USA Price: USD 4,995

Register for this 2018 course now at 2017 rate.

What is Introduction to Cancer: Focus on Solid Tumors?

  • A two-day face-to-face intensive cancer course presented by leading specialists.
  • A comprehensive overview of cancer & major solid tumors designed to meet the educational needs of professionals from the pharmaceutical, medical technology, biotechnology &associated industries
  • Eminent specialist physicians and respected experts share their knowledge and experience with delegates.
  • Participants are provided with current information to better understand the terminology and classification of cancer and the principle issues in its treatment
  • The day is interactive throughout. Learning is made easy through motivational lectures, lively discussion and  thought provoking question & answer (Q&A).
  • Ideal for individuals with little understanding of cancer and its treatment. Equally, beneficial to those with existing basic knowledge.

What will I learn from this cancer course?

This cancer course will include:

  • A review of the commonly available anti-cancer drugs including immunotherapies with emphasis on mode of action, dose intensity and chemotherapy regimes
  • A detailed study of the range of side-effects of cancer treatments
  • Quality of life issues in terms of overall assessment and result interpretation
  • The treatment of major tumor types: breast, lung, melanoma, upper gastrointestinal (GI), colorectal, ovarian and prostate cancer. Each session is presented by clinicians active in these areas and focus on overall patient presentation and management, cancer diagnosis and staging. Following each session our experts will lead delegates in interactive group discussion on the key issues relating to effective management of each tumor type
  • New drug development and identification of new pharmacological targets of particular interest and value. Clinical trial design issues will also be included.


  • Cancer: Terminology and classification
  • Anti-cancer drugs & side effects including immunotherapies
  • New developments in cancer therapy
  • Introduction to the major tumor types: breast, lung, melanoma, upper gastrointestinal (GI), colorectal, ovarian and prostate cancer
  • Clinical trials

cancer course

Faculty includes:

Stéphanie Gaillard, MD, Director, Gynecologic Cancers, Assistant Professor of Oncology, Assistant Professor of Gynecology & Obstetrics, Johns Hopkins Kimmel Cancer Center,
Baltimore, USA
Jeffrey Crawford MD, George Barth Geller Professor for Research in Cancer, Co-Director, Solid Tumor Therapeutics Program, Duke Cancer Center, North Carolina, USA
Bert O’Neil MD, Professor of Medicine, Director, Phase 1 and GI Oncology Program, Simon Cancer Center, Indiana University School of Medicine, Indianapolis, USA
Jeffrey Peppercorn MD, Associate Professor Department of Medicine Harvard Medical School and Director, Survivorship Program, Massachusetts General Hospital, Boston, USA
Susan Slovin MD, Attending Physician, Member,Genitourinary Oncology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, Professor of Medicine, Weill-Cornell Medical College, New York, USA

Is this cancer course for me?

Introduction to Cancer: Focus on Solid Tumors is designed to meet the broad information and education requirements of a range of pharmaceutical and biotech personnel from R&D, medical affairs, regulatory, strategic marketing and many others from both science and business functions.

More courses